-

Piper Sandler Expands Investment Banking with the Hiring of James Reilly

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of James (“Jim”) Reilly as a managing director in the Minneapolis office. He will co-lead investment banking coverage of the vehicle aftermarket.

Prior to joining Piper Sandler, Reilly was a managing director covering the automotive aftermarket at Lazard. He has over 10 years of investment banking experience advising public and private companies, as well as financial sponsors, on mergers & acquisitions, divestitures, leveraged buyouts, growth capital raises and refinancing.

“We are pleased to have Jim co-lead the effort around the vehicle aftermarket,” said Matt Sznewajs, co-head of diversified industrials & services investment banking at Piper Sandler. “Jim’s vast experience in the aftermarket provides him with firsthand knowledge of the aftermarket and makes him well-qualified to lead this growing area of our business.”

“The firm could not have hired a more-experienced aftermarket banker than Jim,” said Treavor Hill, managing director, diversified industrials & services investment bank at Piper Sandler. “He has a deep rolodex of relationships in our sector and is known for his impressive thought leadership in growing aftermarket verticals including e-commerce retailing, specialized parts distribution, and a broad range of aftermarket services. He is also a great cultural fit for our dedicated eight-person aftermarket banking team. I’m really excited for this next chapter of our practice with Jim.”

Reilly earned a bachelor’s degree in public policy from Hamilton College and a Master of Business Administration degree from the University of Minnesota.

ABOUT PIPER SANDLER

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; and in Hong Kong through Piper Sandler Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.

©2022. Since 1895. Piper Sandler Companies. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036

Contacts

Pamela Steensland
Tel: 612 303-8185
pamela.steensland@psc.com

Piper Sandler Companies

NYSE:PIPR

Release Summary
Piper Sandler Expands Investment Banking with the Hiring of James Reilly
Release Versions

Contacts

Pamela Steensland
Tel: 612 303-8185
pamela.steensland@psc.com

More News From Piper Sandler Companies

Piper Sandler Strengthens Fixed Income Platform with the Addition of Distressed Debt and Special Asset Group

NEW YORK--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the additions of John Mori and Eric Friel as managing directors to lead a new group that will focus on distressed debt and special assets. Mori will be based in Greenwich and Friel will be in New York, both reporting to Michael Piper, head of fixed income at Piper Sandler. The distressed debt and special asset group will source and trade specialized credit products, including distr...

Piper Sandler Companies Reports First Quarter 2026 Results; Increases Quarterly Dividend to $0.20 Per Share

MINNEAPOLIS--(BUSINESS WIRE)--The complete earnings release can be found on the firm's website at pipersandler.com/earnings...

Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Patrick McCormack

MINNEAPOLIS & SAN FRANCISCO--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Patrick McCormack, M.D. as a managing director in the healthcare investment banking group. McCormack will be based in San Francisco and focused on advising biopharma companies on mergers and acquisitions and capital-raising transactions. “We are excited to welcome Patrick to the healthcare investment banking team. His deep expertise advising bioph...
Back to Newsroom